Kymriah became the first CAR-T cell therapy to receive regulatory approval when it was approved by the FDA in August 2017. Source: BioSpace

Thirty years ago, neurologist Leonard S. Schliefer, MD, PhD, founded Regeneron, a life sciences company dedicated to discovering, developing and bringing new medications to the patients who need them. Source:…

After a two year absence, Aveo returned to the halls of the key event with a drug newly approved for use in Europe and possibly poised for approval in the…

Chinese interest in the J&J unit comes as the market for diabetes care in China is expected to grow rapidly. Source: BioSpace

The company could be hoping the new hire will provide a consultative resource for all health-care regulatory issues. Source: BioSpace

The U.S. Food and Drug Administration is set to rule on Tavalisse (fostamatinib disodium), an oral spleen tyrosine kinase (SYK) inhibitor, for adult patients with chronic or persistent immune thrombocytopenia…

The Suzhou-based cancer-drug maker has been discussing a valuation of more than $1 billion. Source: BioSpace

Here are three biopharma stocks worth keeping an eye on. Source: BioSpace

The purpose of the subsidiary is to support the Company’s Japanese clinical and radiopharmaceutical manufacturing activities and to establish a commercial footprint in the Japan, an important market for Telix’s…

This not the first time Maraganore has tweeted his support for the benefits of immigration. Source: BioSpace